No Data
No Data
Skye Bioscience to Participate in SXSW Session on Obesity
We're Hopeful That Skye Bioscience (NASDAQ:SKYE) Will Use Its Cash Wisely
Skye Bioscience CEO Punit Dhillon to Present at TD Cowen 45th Annual Health Care Conference
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Smaller Biotechs See New Mechanisms of Actions as Future of Obesity Treatments
Cantor Fitzgerald Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $14